Cite
HARVARD Citation
Gramatzki, D. et al. (2018). Bevacizumab may improve quality of life, but not overall survival in glioblastoma: an epidemiological study. Annals of oncology. pp. 1431-1436. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Gramatzki, D. et al. (2018). Bevacizumab may improve quality of life, but not overall survival in glioblastoma: an epidemiological study. Annals of oncology. pp. 1431-1436. [Online].